TNFSF13 and rheumatoid arthritis: Strikingly, although APRIL was detectable in most samples for patients with RA (83%; P < 0.0001) compared with healthy donors (3%), no statistically significant difference in detectable levels of BLyS was found in patients with RA (33%) compared with the healthy donor samples (18%) (Table 1).